US Patent Litigations are now available. Check here

Explore Prothera Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2945962Apr 17, 2019Methods For Isolating Blood Products From An Inter-Alpha Inhibitor Protein-Depleted Blood Product Material1